Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 364.89 million as of December 5, 2025. Its market cap has increased by 167.88% in one year.

Market Cap

364.89M

Enterprise Value

373.64M

Revenue

55.93M

Ranking

n/a

PE Ratio

16.44

Stock Price

18.28

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 364.89M, an increase of 18.07%. That is a compound annual growth rate of 0.88%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	364.89M	109.52%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	38.37M	-66.14%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Roche Holding AG	268.47B
Novartis AG	203.78B
Lonza Group AG	38.88B
Galderma Group AG	38.74B
Alcon	31.21B
Sandoz Group AG	24.68B
Straumann Holding AG	14.49B
Sonova Holding AG	11.82B

Market Cap Rankings